ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 152 filers reported holding ENANTA PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 1.74 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,215,000 | +185.2% | 23,415 | +310.8% | 0.01% | +150.0% |
| Q4 2021 | $426,000 | +68.4% | 5,700 | +15.7% | 0.00% | -75.0% |
| Q1 2020 | $253,000 | -15.9% | 4,925 | -23.4% | 0.02% | -40.7% |
| Q3 2017 | $301,000 | +4.5% | 6,427 | -31.2% | 0.03% | -6.9% |
| Q1 2017 | $288,000 | -5.0% | 9,336 | -17.9% | 0.03% | -43.1% |
| Q3 2016 | $303,000 | -8.5% | 11,376 | -24.2% | 0.05% | -31.1% |
| Q2 2016 | $331,000 | -7.0% | 15,015 | +24.0% | 0.07% | -49.0% |
| Q1 2016 | $356,000 | – | 12,108 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 1,546,097 | $66,590,000 | 9.91% |
| RA Capital Management | 1,539,586 | $66,310,000 | 6.70% |
| SENZAR ASSET MANAGEMENT, LLC | 255,128 | $10,988,000 | 4.20% |
| INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 158,315 | $6,819,000 | 1.56% |
| Sarissa Capital Management LP | 105,000 | $4,522,000 | 1.54% |
| Ghost Tree Capital, LLC | 50,000 | $2,154,000 | 1.52% |
| BENNETT LAWRENCE MANAGEMENT L L C/NY | 118,445 | $5,102,000 | 0.90% |
| WALL STREET ASSOCIATES | 219,200 | $9,441,000 | 0.81% |
| Granite Point Capital Management, L.P. | 25,000 | $1,077,000 | 0.74% |
| BAILARD, INC. | 91,500 | $3,941,000 | 0.61% |